**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 10377-48-7 |Lithium sulfate, anhydrous | 99 | 233-820-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed.Hygroscopic (absorbs moisture from the air).The
toxicological properties of this material have not been fully
investigated.Possible risks of irreversible effects.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological
properties of this substance have not been fully investigated. Large
doses of lithium may cause dizziness, prostration, and kidney
damage. Dehydration, weight loss, slurred speech, blurred vision,
sensory loss, ataxia (failure of muscular coordination), tremors, and
convulsions may occur.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated.
Chronic:
Prolonged or repeated exposure may cause adverse reproductive
effects. Laboratory experiments have resulted in mutagenic effects.
Human systemic effects may include coma.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Substance
is noncombustible.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Avoid
breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin,
and clothing. Avoid ingestion and inhalation. Use only in a chemical
fume hood.
Storage:
Keep container closed when not in use. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances. Store protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 10377-48-7:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 859 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Freely Soluble.
Specific Gravity/Density: 2.2200g/cm3
Molecular Formula: Li2O4S
Molecular Weight: 109.94
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, exposure to
moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Oxides of sulfur, irritating and toxic fumes and gases, oxides of
lithium.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 10377-48-7: OJ6419000
LD50/LC50:
CAS# 10377-48-7: Oral, mouse: LD50 = 1190 mg/kg; Oral, mouse: LD50 =
1190 mg/kg; Oral, rat: LD50 = 613 mg/kg.
Oral, woman: TDLo = 6 mg/kg (Human systemic effects =
Carcinogenicity:
Lithium sulfate, anhydrous -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 10377-48-7: 1
Canada
CAS# 10377-48-7 is listed on Canada's DSL List.
CAS# 10377-48-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 10377-48-7 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 3/22/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
(R)-(-)-sec-Butanol, 99%
| 78-92-2 |
|
4-Acetamidobenzoic acid
| 556-08-1 |
|
5,6-Dimethyl-1H-Benzotriazole Hydrate, 99%
| 4184-79-6 |
|
Alpha-Methyl-1-Piperidineethanol, 97%
| 934-90-7 |
|
3-Bromobenzyl Bromide, 95%
| 823-78-9 |
|
d-(-)-Quinic acid, 98%
| 77-95-2 |
|
3-(Chlorosulfonyl)benzoyl Chloride, 98% (Titr.)
| 4052-92-0 |
|
3-Chloro-4-Hydroxyphenylacetic Acid 99%
| 33697-81-3 |
|
n-Tosyl-3-pyrrolecarboxylic acid, 96%
| 106058-86-0 |
|
Methylenedithiocyanate, 98%
| 6317-18-6 |
|
Tri-n-butylphosphine, 95%
| 998-40-3 |
|
Neocuproine, 99%
| 484-11-7 |
|
M-Tolylurea, 96%
| 63-99-0 |
|
Nonadecanol, 99+%
| 1454-84-8 |
|
Lithium sulfate, anhydrous, 99%
| 10377-48-7 |
|
6-Acetamidohexanoic Acid, 99%
| 57-08-9 |
|
5,5-Dimethyloxazolidine-2,4-Dione, 99%
| 695-53-4 |
|
Tetramethylammonium nitrate
| 1941-24-8 |
|
1,2:5,6-Di-O-Cyclohexylidene-Alpha-D-Gluco Furanose, 96%
| 23397-76-4 |
|
Ethyl benzoylacetate, 97%
| 94-02-0 |
|
3-(1-Hydroxyethyl)aniline, 98%
| 2454-37-7 |
|
2-Deoxy-D-Glucose, 99%
| 154-17-6 |
|
1-Pyrrolidino-1-cyclopentene, 98%
| 7148-07-4 |
|
1,1',3,3,3',3'-Hexamethylindodicarbocyanine iodide, laser grade, 99%
| 36536-22-8 |
|
3-Amino-5-methylthio-1h-1,2,4-triazole
| 45534-08-5 |
|
Triptycene, 99% (HPLC)
| 477-75-8 |
|
2-Bromoanisole, 97%
| 578-57-4 |
|
2-Phenylphenol, 99+%
| 90-43-7 |
|
3-Acetylthiophene, 98%
| 1468-83-3 |
|
2,5-Diphenyl-1,3,4-oxadiazole, 97%
| 725-12-2 |
|
(D,L)-1-Aminoethylphosphonic Acid, 97%
| 6323-97-3 |
|
2,3,5,6-Tetrafluoroaniline, 98%
| 700-17-4 |
|
4'-Nitroacetanilide (Pract)
| 104-04-1 |
|
4-Aminobenzophenone, 98%
| 1137-41-3 |
|
3-Acetylbenzenesulfonyl fluoride, 99%
| 709-60-4 |
|
1,2:5,6-Di-O-Cyclohexylidene-3-O-Methyl-Alpha-D-Glucofuranose, 98%
| 13440-19-2 |
|
Potassium tetrachloroplatinate(II)
| 10025-99-7 |
|
Diethyl Benzylphosphonate, 99%
| 1080-32-6 |
|
4-Aminophthalimide, 97% (UV-Vis)
| 3676-85-5 |
|
1-Heptanesulfonic acid sodium salt pre- mixed concentrate
| 0-00-0 |
|
4-(2-Aminoethyl)-Benzenesulfonamide Monohydrochloride, 99+%
| 42286-14-6 |
|
Tetraheptylammonium Bromide, 99%
| 4368-51-8 |
|
Methyl Valerate, 99% (GC)
| 624-24-8 |
|
Duolite c 206a
| |
|
4'-Aminoacetophenone, 99%
| 99-92-3 |
|
Ricinoleic Acid (Pract), 85% Castor Oil Fatty Acid
| 141-22-0 |
|
3-Chlorobenzyl Chloride, 98%
| 620-20-2 |
|
Carbonyl Cyanide M-Chlorophenylhydrazone, 99+%
| 555-60-2 |
|
1,3-Dimethyladamantane, 99+%
| 702-79-4 |
|
Dl-1,4-dibromo-2,3-butanediol,95%
| 299-70-7 |
|
|